Skip navigation Consumer Fund Healthcare Info & Comm Technology Internet & Digital Media

OpGen

OpGen is commercializing a novel single molecule DNA analysis technology, "Optical Mapping", for rapid identification and analysis of microorganisms. The system can be used to obtain detailed genetic information with no requirement for prior sequence data, PCR, cloning, or probes. Applications of the new commercial systems include clinical microbial analysis, forensic microbiology and the development of novel molecular diagnostic products.

Recent News

Industry Veteran Douglas White Appointed Chief Executive Officer of OpGen

OpGen Launches Argus Optical Mapping System for Automated, Microbial Whole Genome Analysis

OpGen’s Strategic Investment With In-Q-Tel Yields Commercial Availability of Optical Mapping Instrument

OpGen Announces Strategic Investment and Technology Advancement Agreement with In-Q-Tel

OpGen Announces $23.6 Million Series A Financing